zum Inhalt springen

Fachbereich Veterinärmedizin


Service-Navigation

    Publikationsdatenbank

    Combination immunotherapy with anti-PD-L1 antibody and depletion of regulatory T cells during acute viral infections results in improved virus control but lethal immunopathology (2020)

    Art
    Zeitschriftenartikel / wissenschaftlicher Beitrag
    Autoren
    David, Paul
    Drabczyk-Pluta, Malgorzata
    Pastille, Eva
    Knuschke, Torben
    Werner, Tanja
    Honke, Nadine
    Megger, Dominik A.
    Akhmetzyanova, Ilseyar
    Shaabani, Namir
    Eyking-Singer, Annette
    Cario, Elke
    Kershaw, Olivia (WE 12)
    Gruber, Achim D. (WE 12)
    Tenbusch, Matthias
    Dietze, Kirsten K.
    Trilling, Mirko
    Liu, Jia
    Schadendorf, Dirk
    Streeck, Hendrik
    Lang, Karl S.
    Xie, Youhua
    Zimmer, Lisa
    Sitek, Barbara
    Paschen, Annette
    Westendorf, Astrid M.
    Dittmer, Ulf
    Zelinskyy, Gennadiy
    Quelle
    PLoS pathogens
    Bandzählung: 16
    Heftzählung: 3
    Seiten: e1008340
    ISSN: 1553-7374
    Sprache
    Englisch
    Verweise
    URL (Volltext): https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1008340
    DOI: 10.1371/journal.ppat.1008340
    Pubmed: 32226027
    Kontakt
    Institut für Tierpathologie

    Robert-von-Ostertag-Str. 15
    14163 Berlin
    +49 30 838 62450
    pathologie@vetmed.fu-berlin.de

    Abstract / Zusammenfassung

    Combination immunotherapy (CIT) is currently applied as a treatment for different cancers and is proposed as a cure strategy for chronic viral infections. Whether such therapies are efficient during an acute infection remains elusive. To address this, inhibitory receptors were blocked and regulatory T cells depleted in acutely Friend retrovirus-infected mice. CIT resulted in a dramatic expansion of cytotoxic CD4+ and CD8+ T cells and a subsequent reduction in viral loads. Despite limited viral replication, mice developed fatal immunopathology after CIT. The pathology was most severe in the gastrointestinal tract and was mediated by granzyme B producing CD4+ and CD8+ T cells. A similar post-CIT pathology during acute Influenza virus infection of mice was observed, which could be prevented by vaccination. Melanoma patients who developed immune-related adverse events under immune checkpoint CIT also presented with expanded granzyme-expressing CD4+ and CD8+ T cell populations. Our data suggest that acute infections may induce immunopathology in patients treated with CIT, and that effective measures for infection prevention should be applied.